Pharmacokinetics, Brain Hippocampus and Cortex, and Mitochondrial Accumulation of a New Generation of Lipophilic Redox-Active Therapeutic, Mn(III) Meso Tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin, MnTnBuOE-2-PyP5+, in Comparison with its Ethyl and N-hexyl Analogs, MnTE-2-PyP5+ and MnTnHex-2-PyP5+

Spasojevic, IvanWeitner, TinTovmasyan, ArtakSheng, HuaxinMiriyala, SumitraLeu, DavidRajic, ZrinkaWarner, David SClair, Daret StHuang, Ting-TingBatinic-Haberle, Ines2021-06-012021-06-012013-110891-58491873-4596https://hdl.handle.net/10161/23300Science & TechnologyLife Sciences & BiomedicineBiochemistry & Molecular BiologyEndocrinology & MetabolismPharmacokinetics, Brain Hippocampus and Cortex, and Mitochondrial Accumulation of a New Generation of Lipophilic Redox-Active Therapeutic, Mn(III) Meso Tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin, MnTnBuOE-2-PyP5+, in Comparison with its Ethyl and N-hexyl Analogs, MnTE-2-PyP5+ and MnTnHex-2-PyP5+Journal article2021-06-01